mk-8892
Small moleculeexperimental
Clinical trial activity
4 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Mar 1, 2013 (NCT01798849)
Timeline
2010s
- Jan 1, 2013
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mk-8892
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02078557 | Phase 1 | May 1, 2014 | Merck |
| NCT01926509 | Phase 1 | Nov 1, 2013 | Merck |
| NCT01934647 | Phase 1 | Nov 1, 2013 | Merck |
| NCT01798849 | Phase 1 | Mar 1, 2013 | Merck |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Merck | For profit | 4 | 4 | 1 | 2013 |
1 organizations
Page 1 / 1